Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
Alimentary Pharmacology & Therapeutics|June 8, 2011
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's diseaseM A Kamm, S B Hanauer, R Panaccione, et al.
Inflammatory Bowel Diseases|June 1, 2001
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot studyB E Sands, W J Tremaine, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2013
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's diseaseT Dassopoulos, M C Dubinsky, J L Bentsen, et al.
Gastroenterology|August 28, 1998
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study groupS B Hanauer, M Robinson, R Pruitt, et al.
Gastroenterology|December 13, 2000
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study GroupR N Fedorak, A Gangl, C O Elson, et al.
Human Brain Mapping|September 9, 2017
Frequency-specific neuromodulation of local and distant connectivity in aging and episodic memory functionSimon W Davis, Bruce Luber, David L K Murphy, et al.
Gastroenterology|October 26, 2001
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trialW J Sandborn, S B Hanauer, S Katz, et al.
Inflammatory Bowel Diseases|March 4, 2000
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998C Gasche, J Scholmerich, J Brynskov, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2010
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapyS Lichtiger, D G Binion, D C Wolf, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2018
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study)A B Friedman, S J Brown, P Bampton, et al.
Pageof 16